Overview
Investors 1
| Date | Name | Website |
| Sign up to see | Sign up to see | Sign up to see |
Funding Rounds 1
| Date | Series | Amount | Investors |
| Sign up to see | Sign up to see | Sign up to see | Sign up to see |
Mentions in press and media 14
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Oct 30, 2014 | West Coast Biotech Roundup: Amgen, Inslee, Fibrogen, Receptos & More | Share Share on Facebook Share on Twitter LinkedIn Email Reprints Amgen keeps adding to the layoffs, the governor of Washington has a lot to say to Xconomy about his state’s life sciences industry, and San Francisco’s Fibrogen hopes to crank... |
| Jul 31, 2013 | If you have a horse in the $2.4B A-fib race, hedge your bets with these 3 strategies | It’s a good time to enter the EP-mapping and ablation device market, as Millennium Research Group reports, the more and more popular A-fib ablation procedure will drive those areas toward a value of more than $2.4 billion by 2021. The incre... |
| May 13, 2013 | Heart Rhythm Society 2013 Scientific Session wrap-up | By Westby G. Fisher, MD, FACC As the Heart Rhythm Society’s 2013 Scientific Sessions are a thing of the past, it is interesting to reflect on what constituted the main thrusts occurring our field. Summarizing thousands of abstracts and hund... |
| Apr 26, 2013 | Topera Collects $25M in Series C Funding | San Diego-based Topera Inc. has announced a $25 million series C financing round to commercialize its medical device that treats irregular heartbeats. The funds will also be used to grow the company’s research and development pipeline and i... |
| Apr 26, 2013 | Topera details $25M Series C round | Wall Street Beat | Topera said a new backer, New Enterprise Assoc., led a $25 million Series C round first reported by MassDevice.com last month, with an unnamed "strategic industry partner" joining the round. The San Diego, Calif.-based startup, wh... |
| Apr 26, 2013 | Topera Announces $25M Series C | SAN DIEGO, CA, Medical device company that has developed a novel mapping and targeting system, has completed a $25 million Series C financing round. >> Click here for more funding data on Topera >> To export Topera funding d... |
| Apr 25, 2013 | Topera Takes $25M More For Medical 3D Analysis System | In a bid to help bring its products to market, San Diego-based Topera Medical said Thursday that it has raised $25M in a Series C financing, which will go towards its 3D analysis and mapping system for treating atrial fibrillation. The new ... |
| Apr 25, 2013 | Topera Completes $25M Series C Financing Round | Topera, Inc., a San Diego, CA-based medical device company that has developed a novel mapping and targeting system for the identification of the sources that sustain complex cardiac arrhythmias, including atrial fibrillation, completed a $2... |
| Mar 18, 2013 | Funding: Topera Medical raises $25 million | Medical device start-up Topera Medical closed a $25 million funding round, according to federal Securities & Exchange Commission filings. The San Diego, Calif.-based startup, which came out of stealth mode at the Heart Rhythm Society me... |
Reviews 0
FAQ about Topera
When was Topera founded?
Topera was founded in 2010.
How much funding has Topera raised?
Topera has raised $25M in total across 1 funding round.
What has the press written about Topera?
Parsers VC has collected 14 articles mentioning Topera, among them “West Coast Biotech Roundup: Amgen, Inslee, Fibrogen, Receptos & More” (Oct 30, 2014) and “If you have a horse in the $2.4B A-fib race, hedge your bets with these 3 strategies” (Jul 31, 2013).
Is Topera still active?
Topera is probably closed: its latest activity on Parsers VC dates from Jul 6, 2021.